pioglitazone amplifies the decrease in hba1c and prevents the increase in plasma ketone caused by dapagliflozin in type 1 diabetes patients

R. DeFronzo; M. Abdul-Ghani; G. Baskoy; A. Nakhleh; S. Abdelgani; F. Al-Mulla; M. Abu-Farha; F. Alajmi; T. Alessa; N. Shehadeh

pioglitazone amplifies the decrease in hba1c and prevents the increase in plasma ketone caused by dapagliflozin in type 1 diabetes patients

R. DeFronzo
, M. Abdul-Ghani
, G. Baskoy
, A. Nakhleh
, S. Abdelgani
, F. Al-Mulla
, M. Abu-Farha
, F. Alajmi
, T. Alessa
, N. Shehadeh

Dasman Diabetes Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Pages (from-to)	S60-S61
Journal	Diabetologia
Volume	67
State	Published - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Funding Agency

Kuwait Foundation for the Advancement of Sciences

Cite this

@article{78ec64b7e19a4c078060f37c43e073a2,

title = "pioglitazone amplifies the decrease in hba1c and prevents the increase in plasma ketone caused by dapagliflozin in type 1 diabetes patients",

author = "R. DeFronzo and M. Abdul-Ghani and G. Baskoy and A. Nakhleh and S. Abdelgani and F. Al-Mulla and M. Abu-Farha and F. Alajmi and T. Alessa and N. Shehadeh",

year = "2024",

language = "American English",

volume = "67",

pages = "S60--S61",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - pioglitazone amplifies the decrease in hba1c and prevents the increase in plasma ketone caused by dapagliflozin in type 1 diabetes patients

AU - DeFronzo, R.

AU - Abdul-Ghani, M.

AU - Baskoy, G.

AU - Nakhleh, A.

AU - Abdelgani, S.

AU - Al-Mulla, F.

AU - Abu-Farha, M.

AU - Alajmi, F.

AU - Alessa, T.

AU - Shehadeh, N.

PY - 2024

Y1 - 2024

M3 - Article

SN - 0012-186X

VL - 67

SP - S60-S61

JO - Diabetologia

JF - Diabetologia

ER -